Literature DB >> 33385297

Herpes Simplex Virus-1 and -2 Rapid Detection in Whole Blood.

Wei Zhen1,2, Gregory J Berry3,4.   

Abstract

BACKGROUND: Disseminated herpes simplex virus (HSV) infection has high morbidity and mortality, particularly in neonates, and requires rapid diagnosis for proper treatment. Currently, there are no US FDA-approved assays available to perform HSV testing on blood.
OBJECTIVES: Our goal was to evaluate the analytical sensitivity and clinical performance of an available sample-to-answer real-time polymerase chain reaction (PCR) platform used as a laboratory-developed test (LDT) for the detection of HSV-1 and -2 in whole blood (WB).
METHODS: A clinical comparison study comparing a real-time PCR reference assay to a LDT based on the DiaSorin Simplexa Direct assay kit was performed. Analytical sensitivity studies comparing WB to the FDA-approved specimen type, cerebrospinal fluid (CSF), were also conducted with contrived quantified HSV-1 and -2 samples in WB and CSF matrix.
RESULTS: In total, 102 samples were tested using the LDT and reference assay for the clinical correlation study, with 91 negative and 10 positive results for HSV-1 (n = 7) and HSV-2 (n = 3), exhibiting 100% concordance with comparator results. The overall limit of detection (LoD) for HSV-1 and HSV-2 in WB was comparable to that seen in CSF, with the calculated 95% LoD for blood being 1489 ± 16 copies/ml for HSV-1 and 1187 ± 18 copies/ml for HSV-2 and for CSF being 1168 ± 17 copies/ml for HSV-1 and 953 ± 21 copies/ml for HSV-2.
CONCLUSIONS: The performance of the LDT for detection of HSV-1 and HSV-2 in WB specimens is adequate for clinical use. The LoD for HSV-1 and HSV-2 is comparable to that in CSF, the FDA-approved specimen type.

Entities:  

Year:  2021        PMID: 33385297     DOI: 10.1007/s40291-020-00503-5

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  10 in total

1.  Could neonatal disseminated herpes simplex virus infections be treated earlier?

Authors:  Katy J Fidler; Christine M Pierce; W David Cubitt; Vas Novelli; Mark J Peters
Journal:  J Infect       Date:  2004-08       Impact factor: 6.072

Review 2.  Herpes simplex virus.

Authors:  Linda A Waggoner-Fountain; Leigh B Grossman
Journal:  Pediatr Rev       Date:  2004-03

3.  Viremia in neonatal herpes simplex virus infections.

Authors:  C Diamond; K Mohan; A Hobson; L Frenkel; L Corey
Journal:  Pediatr Infect Dis J       Date:  1999-06       Impact factor: 2.129

4.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L Corey; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S Weller; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

Review 5.  Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update.

Authors:  John Brock Harris; Amy P Holmes
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Mar-Apr

6.  Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy.

Authors:  Sarah S Long; Tamara E Pool; Jennifer Vodzak; Irini Daskalaki; Jane M Gould
Journal:  Pediatr Infect Dis J       Date:  2011-07       Impact factor: 2.129

Review 7.  Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections.

Authors:  William J Muller; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 8.  Treatment of herpes simplex virus infections.

Authors:  Rebecca C Brady; David I Bernstein
Journal:  Antiviral Res       Date:  2004-02       Impact factor: 5.970

Review 9.  Maternal and neonatal herpes simplex virus infections.

Authors:  Lawrence Corey; Anna Wald
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

10.  Whole blood polymerase chain reaction in a neonate with disseminated herpes simplex virus infection and liver failure.

Authors:  Jennifer A Scoble; Mark A Underwood
Journal:  AJP Rep       Date:  2013-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.